Literature DB >> 29616126

Dendritic cells loaded with HeLa-derived exosomes simulate an antitumor immune response.

Guoping Ren1, Yanhong Wang1, Shexia Yuan1, Baolian Wang1.   

Abstract

The aim of the present study was to investigate the effect of loading dendritic cells (DCs) with HeLa-derived exosomes on cytotoxic T-lymphocyte (CTL) responses, and the cytotoxic effects of CTL responses on the HeLa cell line. Ultrafiltration centrifugation combined with sucrose density gradient ultracentrifugation was applied to isolate exosomes (HeLa-exo) from the supernatant of HeLa cells. Morphological features of HeLa-exo were identified by transmission electron microscopy (TEM), and the expression of cluster of differentiation (CD)63 was detected by western blotting. Next, monocytes were isolated from peripheral blood and cultured with the removal of adherent cells to induce DC proliferation. DCs were then phenotypically characterized by flow cytometry. Finally, MTT assays were performed to analyze the effects of DCs loaded with HeLa-exo on T cell proliferation and cytotoxicity assays to evaluate the effect of CTL responses on HeLa cells. TEM revealed that HeLa-exo exhibit typical cup-shaped morphology with a diameter range of 30-100 nm. It was also identified that the CD63 surface antigen is expressed on HeLa-exo. Furthermore, monocyte-derived DCs were able to express CD1a, suggesting that DC induction was a success. DCs exhibited hair-like protrusions and other typical dendritic cell morphology. Furthermore, DCs loaded with HeLa-exo could enhance CTL proliferation and the cytotoxic activity of CTLs compared with DCs without HeLa-exo (P<0.05). In conclusion, DCs loaded with HeLa-exo may promote T cell proliferation and induce CTL responses to inhibit the growth of cervical cancer cells in vitro.

Entities:  

Keywords:  HeLa cell lysates; T cells; dendritic cells; exosomes

Year:  2018        PMID: 29616126      PMCID: PMC5876420          DOI: 10.3892/ol.2018.8126

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  18 in total

Review 1.  Dendritic Cell-Based Cancer Vaccines.

Authors:  Patricia M Santos; Lisa H Butterfield
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

2.  Increasing vaccine potency through exosome antigen targeting.

Authors:  Zachary C Hartman; Junping Wei; Oliver K Glass; Hongtao Guo; Gangjun Lei; Xiao-Yi Yang; Takuya Osada; Amy Hobeika; Alain Delcayre; Jean-Bernard Le Pecq; Michael A Morse; Timothy M Clay; Herbert K Lyerly
Journal:  Vaccine       Date:  2011-10-12       Impact factor: 3.641

3.  Tetraspanin-3 regulates protective immunity against Eimeria tenella infection following immunization with dendritic cell-derived exosomes.

Authors:  Emilio del Cacho; Margarita Gallego; Hyun S Lillehoj; Joaquin Quilez; Erik P Lillehoj; Caridad Sánchez-Acedo
Journal:  Vaccine       Date:  2013-07-20       Impact factor: 3.641

4.  Melanoma cell-derived exosomes alter macrophage and dendritic cell functions in vitro.

Authors:  Annamaria Marton; Csaba Vizler; Erzsebet Kusz; Viktoria Temesfoi; Zsuzsa Szathmary; Krisztina Nagy; Zsolt Szegletes; Gyorgy Varo; Laszlo Siklos; Robert L Katona; Vilmos Tubak; O M Zack Howard; Erno Duda; Janos Minarovits; Katalin Nagy; Krisztina Buzas
Journal:  Immunol Lett       Date:  2012-08-08       Impact factor: 3.685

Review 5.  Dendritic cells based immunotherapy.

Authors:  Na Shang; Matteo Figini; Junjie Shangguan; Bin Wang; Chong Sun; Liang Pan; Quanhong Ma; Zhuoli Zhang
Journal:  Am J Cancer Res       Date:  2017-10-01       Impact factor: 6.166

6.  Modeling putative therapeutic implications of exosome exchange between tumor and immune cells.

Authors:  Mingyang Lu; Bin Huang; Samir M Hanash; José N Onuchic; Eshel Ben-Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-22       Impact factor: 11.205

7.  Exosome removal as a therapeutic adjuvant in cancer.

Authors:  Annette M Marleau; Chien-Shing Chen; James A Joyce; Richard H Tullis
Journal:  J Transl Med       Date:  2012-06-27       Impact factor: 5.531

8.  Activated human T cells secrete exosomes that participate in IL-2 mediated immune response signaling.

Authors:  Jessica Wahlgren; Tanya De L Karlson; Pernilla Glader; Esbjörn Telemo; Hadi Valadi
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

Review 9.  Intercellular communication by exosome-derived microRNAs in cancer.

Authors:  Bethany N Hannafon; Wei-Qun Ding
Journal:  Int J Mol Sci       Date:  2013-07-09       Impact factor: 5.923

10.  Exosome-driven transfer of tumor-associated Pioneer Translation Products (TA-PTPs) for the MHC class I cross-presentation pathway.

Authors:  Emilie Duvallet; Mathilde Boulpicante; Takahiro Yamazaki; Chrysoula Daskalogianni; Rodrigo Prado Martins; Sonia Baconnais; Bénédicte Manoury; Robin Fahraeus; Sébastien Apcher
Journal:  Oncoimmunology       Date:  2016-06-21       Impact factor: 8.110

View more
  5 in total

Review 1.  Emerging role of exosomes in cancer progression and tumor microenvironment remodeling.

Authors:  Mahshid Deldar Abad Paskeh; Maliheh Entezari; Sepideh Mirzaei; Amirhossein Zabolian; Hossein Saleki; Mohamad Javad Naghdi; Sina Sabet; Mohammad Amin Khoshbakht; Mehrdad Hashemi; Kiavash Hushmandi; Gautam Sethi; Ali Zarrabi; Alan Prem Kumar; Shing Cheng Tan; Marios Papadakis; Athanasios Alexiou; Md Asiful Islam; Ebrahim Mostafavi; Milad Ashrafizadeh
Journal:  J Hematol Oncol       Date:  2022-06-28       Impact factor: 23.168

2.  Exosomal lncRNA UCA1 modulates cervical cancer stem cell self-renewal and differentiation through microRNA-122-5p/SOX2 axis.

Authors:  Zhihui Gao; Qianqing Wang; Mei Ji; Xiangcui Guo; Li Li; Xiaoke Su
Journal:  J Transl Med       Date:  2021-05-30       Impact factor: 5.531

Review 3.  Exosomes in Immune Regulation.

Authors:  Heidi Schwarzenbach; Peter B Gahan
Journal:  Noncoding RNA       Date:  2021-01-08

Review 4.  The Role of Exosomes in the Female Reproductive System and Breast Cancers.

Authors:  Yuqi Bai; Jie Guo; Zhongshan Liu; Yunfeng Li; Shunzi Jin; Tiejun Wang
Journal:  Onco Targets Ther       Date:  2020-12-08       Impact factor: 4.147

Review 5.  Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy.

Authors:  Marzieh Naseri; Mahmood Bozorgmehr; Margot Zöller; Ehsan Ranaei Pirmardan; Zahra Madjd
Journal:  Oncoimmunology       Date:  2020-06-16       Impact factor: 8.110

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.